# Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat

> **NCT04299633** · PHASE1 · COMPLETED · sponsor: **Akebia Therapeutics** · enrollment: 54 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Vadadustat
- **DRUG:** Sevelamer carbonate
- **DRUG:** Calcium acetate
- **DRUG:** Auryxia®

## Key facts

- **NCT ID:** NCT04299633
- **Lead sponsor:** Akebia Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-15
- **Primary completion:** 2020-08-02
- **Final completion:** 2020-09-28
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2020-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04299633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04299633, "Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of Vadadustat". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04299633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*